A Biomarker Study of Tivozanib in Subjects With Advanced Renal Cell Carcinoma
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Renal Cell Carcinoma
Related studies linked through entity extraction aliases.
Dendritic Cell Vaccination for Patients with Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Bevacizumab and BKM-120 in Patients With Metastatic Renal Cell Carcinoma
- Status
- COMPLETED
- Phase
- PHASE1
Nonmyeloablative Allogeneic Transplant
- Status
- COMPLETED
- Phase
- NA
Caphosol in Oral Mucositis Due to Targeted Therapy
- Status
- COMPLETED
- Phase
- PHASE3
Novel Peptide Vaccination for Patients With Advanced Renal Cell Carcinoma
- Status
- COMPLETED
- Phase
- PHASE1
Brivanib Metastatic Renal Cell Carcinoma
- Status
- TERMINATED
- Phase
- PHASE2
Cytokine Induced Killer Cells Stimulated by DC Immunotherapy for Renal Cell Carcinoma
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
Cancer in Patients With Gabapentin (GPRD)
- Status
- COMPLETED
- Phase
- N/A
The Vascular and Metabolic Effects of Sunitinib in Patients With Metastatic Renal Cell Carcinoma
- Status
- COMPLETED
- Phase
- N/A
Dynamic Contrast Enhancement Computed Tomography for Evaluating Tumor Perfusion in Patients With Metastatic Renal Cell Carcinoma Receiving Targeted Therapies: Renal Cell Carcinoma (RCC) Scramble
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Resection of Pulmonary Metastasis in Clear Cell Renal Cell Carcinoma +/-Adjuvant Sunitinib Therapy (SMAT)
- Status
- UNKNOWN
- Phase
- PHASE2
Temsirolimus (Torisel) Drug Use Investigation (Regulatory Post Marketing Commitment Plan)
- Status
- COMPLETED
- Phase
- N/A
A Trial of Everolimis in Patients With Advanced Renal Cell Carcinoma.
- Status
- COMPLETED
- Phase
- PHASE4
Granulocyte-macrophage Colony-stimulating Factor, Interferon and Interleukin-2 as Adjuvant Treatment for Renal Cancer
- Status
- COMPLETED
- Phase
- PHASE2
A Pilot, Open-label Study of 18F-Fluciclatide PET/CT Imaging in the Evaluation of Anti-angiogenic Therapy in Solid Tumors
- Status
- WITHDRAWN
- Phase
- PHASE1/PHASE2
Circulating Tumors Cells and Circulating Endothelial Cells in Renal Cell Carcinoma
- Status
- COMPLETED
- Phase
- N/A
Study of Vitespen (HSPPC-96, Oncophage ®) for Immune Response Assessment in Participants With Resectable Renal Cell Carcinoma at Intermediate Risk of Recurrence
- Status
- TERMINATED
- Phase
- PHASE2
Study of Hydroxychloroquine Before Surgery in Patients With Primary Renal Cell Carcinoma
- Status
- TERMINATED
- Phase
- PHASE1
Gabapentin and Risk of Pancreatic Cancer and Renal Cancer (GPRD)
- Status
- COMPLETED
- Phase
- N/A